MİTOKONDRİYAL DNA VE KANSER

Yıl 2007, Cilt: 20 Sayı: 2, 127 - 136, 25.06.2015

Cenk Aral Ayşe Özer

Öz

Mitokondriyal DNA' nın, nükleer DNA' ya kıyasla mutasyonlara daha duyarlı olması ve tamir mekanizmalarının sınırlılığı nedeniyle karsinogenezde rol aldığı öne sürülmüştür. Bu derlemede tiroid, kolorektal, meme ve gastrik kanserlerde, mitokondriyal genom kararsızlığı, mitokondriyal DNA mutasyonlarının apoptozis ile ilişkisi ve mitokondriyal genomdaki değişimler değerlendirilmiştir.

Anahtar Kelimeler: Mitokondriyal DNA, Genomik kararsızlık, Apoptozis, Mutasyon, Solid tümörler

Anahtar Kelimeler

Mitokondriyal DNA, Genomik kararsızlık, Apoptozis, Mutasyon, Solid tümörler

Kaynakça

• Scheffler IE, Mitochondria, Wiley-Liss Publication, NY,
• -
• Anderson S, Bankier AT, Barrel BG, et al. Sequence and
• organization of the human mitochondrial genome.
• Nature 1981; 290: 457-465.
• MITOMAP: A human mitochondrial genome database.
• http://www.mitomap.org, 2006.
• Kanki T, Nakayama H, Sasaki N, et al. Mitochondrial
• nucleoid and transcription factor A. Ann NY Acad Sci
• ; 1011: 61-68.
• Larsen NB, Ramussen M, Ramussen LJ. Nuclear and
• mitochondrial DNA repair: similar pathways?
• Mitochondrion 2005; 5: 89-108.
• DiMauro S. Mitochondrial diseases. Biochem Biophys
• Acta 2004; 1658: 80-88.
• Bohr VA. Repair of oxidative DNA damage in nuclear
• and mitochondrial DNA, and some changes with aging
• in mammalian cells. Free Radic Biol Med 2002; 32:
• –812.
• Ide H, Kow YW, Wallace SS. Thymine glycols and urea
• residues in M13 DNA constitute replicative blocks in
• vitro. Nucleic Acids Res 1985; 13: 8035–8052.
• Grollman AP, Moriya M. Mutagenesis by 8-oxoguanine:
• an enemy within. Trends Genet 1993; 9: 246–249.
• Pinz KG, Shibutani S, Bogenhagen DF. Action of
• mitochondrial DNA polymerase at sites of base loss or
• oxidative damage. J Biol Chem 1995; 270: 9202–9206.
• Loft S, Moller P. Oxidative DNA damage and human
• cancer: need for cohort studies. Antioxid Redox Signal
• ; 8: 1021-1031.
• Reid R. Can migratory mitochondrial DNA activate
• oncogenes. Trends Biochem 1983; 8: 190-191.
• Richard SM, Bailliet G, Paez GL, et al. Nuclear and
• mitochondrial genome instability in human breast
• cancer. Cancer Res 2000; 60: 4231-4237.
• Levin DE, Yamasaki E, Ames BN. A new Salmonella
• tester strain, TA97, for the detection of frameshift
• mutagens: a run of cytosines as a mutational hot-spot.
• Mutat Res 1982; 94: 315–330.
• Owen JE, Schultz DW, Taylor A, Smith GR. Nucleotide
• sequence of the lysozyme gene of bacteriophage T4:
• analysis of mutations involving repeated sequences. J
• Mol Biol 1983; 165: 229–248.
• Levinson G, Gutman GA. Slipped-strand mispairing: a
• major mechanism for DNA sequence evolution. Mol
• Biol Evol 1987; 4: 203–221.
• Polyak K, Li Y, Zhu H, et al. Somatic mutations of the
• mitochondrial genome in human colorectal tumours. Nat
• Genet 1998; 20: 291–293.
• Habano W, Nakamura SI, Sugai T. Microsatellite
• instability in the mitochondrial DNA of colorectal
• carcinomas: evidence for mismatch repair systems in
• mitochondrial genome. Oncogene 1998; 17: 1931–1937.
• Habano W, Sugai T, Yoshida T, Nakamura SI.
• Mitochondrial gene mutation, but not large-scale
• deletion, is a feature of colorectal carcinomas with
• mitochondrial microsatellite instability. Int J Cancer
• ; 83: 625–629.
• Bianchi MS, Bianchi NO, Bailliet G. Mitochondrial
• DNA mutations in normal and tumor tissues from breast
• cancer patients. Cytogenet Cell Genet 1995; 71: 99–103.
• Cortopassi GA, Arnheim N. Detection of a specific
• mitochondrial DNA deletion in tissues of older
• individuals. Nuc Acids Res 1990; 18: 6927–6933.
• Livneh Z. Directed mutagenesis method for analysis of
• mutagen specificity: application to ultraviolet-induced
• mutagenesis. Proc Natl Acad Sci USA 1983; 80: 237–
• -
• Flanagan JG, Lefranc MP, Rabbitts TH. Mechanisms of
• divergence and convergence of the human
• immunoglobulin α-1 and α-2 constant region gene
• sequences. Cell 1984; 36: 681–688.
• Kunkel TA. The mutational specificity of DNA
• polymerase-beta during in vitro DNA synthesis:
• production of frameshift, base substitution, and deletion
• mutations. J Biol Chem 1985; 260: 5787–5796.
• Burgart LJ, Zheng J, Shu Q, et al. Somatic
• mitochondrial mutation in gastric cancer. Am J Pathol
• ; 147: 1105–1111.
• De la Chapelle A, Peltomaki P. The genetics of
• hereditary common cancers. Curr Opin Genet Dev 1998;
• : 298-303.
• Peltomaki P. DNA mismatch repair and cancer. Rev
• Mutat Res 2001; 488: 77-85.
• Clayton DA. Replication of animal mitochondrial DNA.
• Cell 1982; 28: 693–705.
• Kunkel TA, Alexander PS. The base substitution fidelity
• of eucaryotic DNA polymerases. Mispairing frequencies,
• site preferences, insertion preferences, and base
• substitution by dislocation. J Biol Chem 1986; 261: 160–
• -
• Pinz KG, Shibutani S, Bogenhagen DF. Action of
• mitochondrial DNA polymerase γ at sites of base loss or
• oxidative damage. J Biol Chem 1995; 270: 9202–9206.
• Faraj A, Fowler DA, Bridges EG, Sommadossi JP.
• Effects of 2′,3′-dideoxynucleosides on proliferation and
• differentiation of human pluripotent progenitors in liquid
• culture and their effects on mitochondrial DNA
• synthesis. Antimicrob Agents Chemother 1994; 38: 924–
• -
• Lewis W, Dalakas MC. Mitochondrial toxicity of
• antiviral drugs. Nat Med 1995; 1: 417–422.
• Ropp PA, Copeland WC. Cloning and characterization
• of the human mitochondrial DNA polymerase γ.
• Genomics 1996; 36: 449–458.
• Zeviani M, Servidei S, Gellera C, et al. An autosomal
• dominant disorder with multiple deletions of
• mitochondrial DNA starting at the D-loop region. Nature
• ; 339: 309–311.
• Lee MS, Kim JA, Park SY. Resistance of ro cells against
• apoptosis. Ann NY Acad Sci 2004; 1011: 146-153.
• Liu CY, Lee CF, Hong CH, Wei YH. Mitochondrial
• DNA mutation and depletion increase the susceptibility
• of human cells to apoptosis. Ann NY Acad Sci 2004;
• : 133-145.
• Shidara Y, Yamagata K, Kanamori T, et al. Positive
• contribution of pathogenic mutations in the
• mitochondrial genome to the promotion of cancer by
• prevention from apoptosis. Cancer Res 2005; 65: 1655-
• -
• Schoeler S, Szibor R, Gellerich FN, et al. Mitochondrial
• DNA deletions sensitize cell to apoptosis at low
• heteroplasmy levels. Biochem Biophys Res Commun
• ; 332: 43-49.
• -
• Marmara Medical Journal 2007;20(2);127-136
• Cenk Aral, et al
• Mitochondrial DNA and cancer
• Mott JL, Zhang D, Stevens M, et al. Oxidative stress is
• not an obligate mediator of disease provoked by
• mitochondrial DNA mutations. Mutat Res 2001; 474:
• –45.
• Park SY, Chang I, Kim JY, et al. Resistance of
• mitochondrial DNA-depleted cells against cell death:
• role of mitochondrial superoxide dismutase. J Biol Chem
• ; 279: 7512–7520.
• Jacques C, Chevrollier A, Loiseau D, et al. mtDNA
• controls expression of the death associated protein 3.
• Exp Cell Res 2006; 312: 737-745.
• Yeh JJ, Lunetta KL, van Orsouw NJ, et al. Somatic
• mitochondrial DNA (mtDNA) mutations in papillary
• thyroid carcinomas and differential mtDNA sequence
• variants in cases with thyroid tumours. Oncogene 2000;
• : 2060–2066.
• Maximo V, Soares P, Lima J, et al. Mitochondrial DNA
• somatic mutations (point mutations and large deletions)
• and mitochondrial DNA variants in human thyroid
• pathology: a study with emphasis on Hurtle cell tumors.
• Am J Pathol 2002; 160: 1857-1865.
• Rogounovitch TI, Saenko VA, Shimizu-Yoshida Y, et
• al. Large deletions in mitochondrial DNA in radiationassociated
• human thyroid tumors. Cancer Res 2002; 62:
• -7041.
• Tong BC, Ha PK, Dhir K, et al. Mitochondrial DNA
• alteations in thyroid cancer. J Surg Oncol 2003; 82: 170-
• -
• Lohrer HD, Hieber L, Zitzelsberger H. Differential
• mutation frequency in mitochondrial DNA from thyroid
• tumors. Carcinogenesis 2002; 23: 1577-1582.
• Maximo V, Lima J, Soares P, et al. Mitochondrial Dloop
• instability in thyroid tumors is not a marker of
• malignancy. Mitochondrion 2005; 5: 333-340.
• Aikhionbare FO, Khan M, Carey D, et al. Is cumulative
• frequency of mitochondrial DNA variants a biomarker
• for colorectal tumor progression? Mol Cancer 2004;
• :30.
• Nishikawa M, Oshitani N, Matsumoto T, et al.
• Accumulation of mitochondrial DNA mutation with
• colorectal carcinogenesis in ulcerative colitis. Br J
• Cancer 2005; 93: 331-337.
• Greaves LC, Preston SL, Tadrous PJ, et al.
• Mitochondrial DNA mutations are established in human
• colonic stem cells, and mutated clones expand by crypt
• fission. Proc Natl Acad Sci 2006; 103: 714-719.
• Lee HC, Yin PH, Lin JC, et al. Mitochondrial genome
• instability and mtDNA depletion in human cancers. Ann
• NY Acad Sci 2005; 1042: 109-122.
• Kose K, Hiyama T, Tanaka S, et al. Somatic mutations
• of mitochondrial DNA in digestive tract cancers. J
• Gastroenterol Hepatology 2005; 20: 1679-1684.
• Lievre A, Chapusot C, Bouvier AM, et al. Clinical value
• of mitochondrial mutations in colorectal cancer. J Clin
• Oncol 2005; 23: 3517-3525.
• Aral C, Kaya H, Ataizi-Çelikel Ç, et al. A novel
• approach for rapid screening of mitochondrial D310
• polymorphism. BMC Cancer 2006; 6:21.
• Tan DJ, Bai RK, Wong LJC. Comprehensive scanning
• of somatic mitochondrial DNA mutations in breast
• cancer. Cancer Res 2002; 62: 972-976.
• Parrella P, Xiao Y, Fliss M, et al. Detection of
• mitochondrial DNA mutations in primary breast cancer
• and fine-needle aspirates. Cancer Res 2001; 61: 7623-
• -
• Parrella P, Seripa D, Matera MG, et al. Mutations of the
• D310 mitochondrial mononucleotide repeat in primary
• tumors cytological specimens. Cancer Lett 2003; 190:
• -77.
• Isaacs C, Cavalli LR, Cohen Y, et al. Detection of LOH
• and mitochondrial DNA alterations in ductal lavage and
• nipple aspirate fluids from high-risk patients. Breast
• Cancer Res Treat 2004; 84: 99-105.
• Zhu W, Qin W, Sauter ER. Large-scale mitochondrial
• mutations and nuclear genome instability in human
• breast cancer. Cancer Detect Prevent 2004; 28: 119-126.
• Dani MAC, Dani SU, Lima SPG, et al. Less
• ∆mtDNA4977 than normal in various types of tumors
• suggests that cancer cells are essentially free of this
• mutation. Genet Mol Res 2004; 3: 395-409.
• Tamura G, Nishizuka S, Maesawa C, et al. Mutations in
• mitochondrial control region DNA in gastric tumors of
• Japanese patients. Eur J Cancer 1999; 35: 316-319.
• Maximo V, Soares P, Seruca R, Sobrinho-Simoes M.
• Comments on: Mutations in mitochondrial control
• region DNA in gastric tumors of Japanese patients,
• Tamura, et al. Eur J Cancer 1999, 35, 316-319. Eur J
• Cancer 1999; 35: 1407-1408.
• Han CB, Li F, Zhao YJ, Ma JM, et al. Variations of
• mitochondrial D-loop region plus downstream gene 12S
• rRNA-tRNAphe and gastric carcinomas. World J
• Gastroenterol 2003; 9: 1925-1929.
• Zhao YB, Yang HY, Zhang XW, Chen GY. Mutation in
• D-loop region of mitochondrial DNA in gastric cancer
• and significance. World J Gastroenterol 2005; 11: 3304-
• -
• Wu CW, Yin PH, Hung WY, et al. Mitochondrial DNA
• mutations and mitochondrial DNA depletion in gastric
• cancer. Genes Chromosomes Cancer 2005; 44:19-28.
• Carew JS, Huang P. Mitochondrial defects in cancer.
• Mol Cancer 2002; 1: 9.
• Penta JS, Johnson FM, Wachsman JT, Copeland WC.
• Mitochondrial DNA in human malignancy. Mutat Res
• ; 488: 119-133.